Stanford, SRI to support development of novel drugs to treat triple-negative breast cancer

… treatment of triple-negative breast cancer.
Close to 20 percent of breast cancers are triple-negative … common receptors that fuel most breast cancer growth. These tumors are unresponsive … in the treatment of triple-negative breast cancer, where unfortunately there are currently …